APA (7th ed.) Citation

EP, M., CS, G., M, P., R, C., AS, R., V, M., . . . BM, C. (2022). Cadherin-3 is a novel oncogenic biomarker with prognostic value in glioblastoma. Molecular oncology, 16(14), 2611. https://doi.org/10.1002/1878-0261.13162

Chicago Style (17th ed.) Citation

EP, Martins, et al. "Cadherin-3 Is a Novel Oncogenic Biomarker with Prognostic Value in Glioblastoma." Molecular Oncology 16, no. 14 (2022): 2611. https://doi.org/10.1002/1878-0261.13162.

MLA (9th ed.) Citation

EP, Martins, et al. "Cadherin-3 Is a Novel Oncogenic Biomarker with Prognostic Value in Glioblastoma." Molecular Oncology, vol. 16, no. 14, 2022, p. 2611, https://doi.org/10.1002/1878-0261.13162.